Francesco Bonella

ERS clinical practice guidelines on treatment of sarcoidosis

Robert P. Baughman, Dominique Valeyre, Peter Korsten et al. · European Respiratory Journal · 2021 · 541 citations · Full text

Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial

Athol U. Wells, Kevin R. Flaherty, Kevin K. Brown et al. · The Lancet Respiratory Medicine · 2020 · 522 citations · Full text

Inbuild Trial, Parallel-group Trial, Advanced Lung Disease +5

Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial

Jürgen Behr, Antje Prasse, Michael Kreuter et al. · The Lancet Respiratory Medicine · 2021 · 490 citations · Full text

Antifibrotic Therapy, Advanced Lung Disease, Idiopathic Pulmonary Fibrosis +6

Phenotypes of organ involvement in sarcoidosis

Jonas C. Schupp, Sandra Freitag‐Wolf, Elena Bargagli et al. · European Respiratory Journal · 2018 · 237 citations · Full text

Immunology, Genetic Epidemiology, Pathology +17

Identification of Diagnostic Criteria for Chronic Hypersensitivity Pneumonitis. An International Modified Delphi Survey

Julie Morisset, Kerri A. Johannson, Kirk D. Jones et al. · American Journal of Respiratory and Critical Care Medicine · 2017 · 227 citations · Full text